.svg){kind=small}
Nov-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In the Arizona market, VET CBD has demonstrated varied performance across different product categories. Notably, in the Edible category, the brand did not make it to the top 30 rankings from August to November 2025, suggesting a potential area for growth or increased competition. However, in November, VET CBD achieved a notable ranking of 4th in the Tincture & Sublingual category, indicating a strong presence and possibly a strategic focus on this product line. This contrast in performance across categories could be indicative of consumer preferences or brand strategy within the state.
In California, VET CBD has consistently maintained its 4th place ranking in the Tincture & Sublingual category from August through November 2025. This stability suggests a solidified brand presence and consumer loyalty in this category, which could be a key driver of their success in the state. The sales figures for this category also show a positive trend, with an increase from September to November, reflecting the brand's successful engagement with its customer base. This consistent performance in California's competitive market highlights VET CBD's potential for sustained growth.
Competitive Landscape
In the competitive landscape of the Tincture & Sublingual category in California, VET CBD consistently maintained its rank at 4th place from August to November 2025, indicating a stable market position. Despite not surpassing its closest competitors, Care By Design and Yummi Karma, which held steady at 3rd and 2nd positions respectively, VET CBD's sales showed a positive trajectory, with a notable increase from September to October. This upward trend in sales suggests a growing consumer preference or effective marketing strategies. Meanwhile, ABX / AbsoluteXtracts and Mary's Medicinals experienced fluctuations in their rankings, with Mary's Medicinals dropping to 8th place in September and October before recovering to 6th in November. These dynamics highlight VET CBD's resilience and potential for further growth in a competitive market.
Notable Products
For November 2025, the top-performing product from VET CBD is the CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz) in the Tincture & Sublingual category, maintaining its number one rank with sales of 1027 units. Following closely is the CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml), which also held steady at the second position with a slight increase in sales. The CBD/THC 10:1 Extra Strength Tincture (500mg CBD, 50mg THC, 60ml, 2oz) improved its rank to third place, showing a notable increase in sales compared to previous months. The CBD/THC 20:1 Extra Strength Pet Tincture (250mg CBD, 25mg THC, 60ml, 2oz) dropped to fourth place despite strong sales earlier in the year. Lastly, the CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) remained in fifth place, continuing its consistent performance over the months.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
